Keratoacanthoma-like eruption associated with pembrolizumab and dupilumab treated by intralesional triamcinolone: A case report

Q3 Medicine

JAAD Case Reports Pub Date : 2025-04-26 DOI:10.1016/j.jdcr.2025.03.036

Raphaella Lambert BA, Elizabeth Rotrosen MD, Hannah Verma BA, Grace Rabinowitz BA, Patricia Heller MD, Nicholas Gulati MD, PhD

引用次数: 0

查看原文本刊更多论文

局部曲安奈德治疗与派姆单抗和杜匹单抗相关的角棘瘤样疹：1例报告

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAAD Case Reports Medicine-Dermatology

CiteScore

2.10

自引率

0.00%

发文量

537

审稿时长

43 days

期刊介绍： The Journal of the American Academy of Dermatology (JAAD), the official scientific publication of the American Academy of Dermatology (AAD), aims to satisfy the educational needs of the dermatology community. As the specialty''s leading journal, JAAD features original, peer-reviewed articles emphasizing: clinical, investigative, and population-based studies healthcare delivery and quality of care research high quality, cost effective, and innovative treatments new diagnostic techniques, and other topics related to the prevention, diagnosis, and treatment of disorders of the skin, hair, and nails. Each issue includes continuing medical education articles designed to fill practice and knowledge gaps in the delivery of dermatologic care. JAAD is also the official venue for practice guidelines established by the AAD. Our ultimate goal is to provide readers with content that advances the breadth and depth of dermatologic expertise by disseminating evidence-based recommendations to improve patient outcomes.